These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12525644)

  • 1. Antibody-mediated targeting of an adenovirus vector modified to contain a synthetic immunoglobulin g-binding domain in the capsid.
    Volpers C; Thirion C; Biermann V; Hussmann S; Kewes H; Dunant P; von der Mark H; Herrmann A; Kochanek S; Lochmüller H
    J Virol; 2003 Feb; 77(3):2093-104. PubMed ID: 12525644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EpCAM- and EGFR-targeted selective gene therapy for biliary cancers using Z33-fiber-modified adenovirus.
    Kawashima R; Abei M; Fukuda K; Nakamura K; Murata T; Wakayama M; Seo E; Hasegawa N; Mizuguchi H; Obata Y; Hyodo I; Hamada H; Yokoyama KK
    Int J Cancer; 2011 Sep; 129(5):1244-53. PubMed ID: 21710497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A strategy for adenovirus vector targeting with a secreted single chain antibody.
    Glasgow JN; Mikheeva G; Krasnykh V; Curiel DT
    PLoS One; 2009 Dec; 4(12):e8355. PubMed ID: 20027223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reductive amination as a strategy to reduce adenovirus vector promiscuity by chemical capsid modification with large polysaccharides.
    Espenlaub S; Wortmann A; Engler T; Corjon S; Kochanek S; Kreppel F
    J Gene Med; 2008 Dec; 10(12):1303-14. PubMed ID: 18837065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX.
    Poulin KL; Lanthier RM; Smith AC; Christou C; Risco Quiroz M; Powell KL; O'Meara RW; Kothary R; Lorimer IA; Parks RJ
    J Virol; 2010 Oct; 84(19):10074-86. PubMed ID: 20631131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished.
    van Beusechem VW; Grill J; Mastenbroek DC; Wickham TJ; Roelvink PW; Haisma HJ; Lamfers ML; Dirven CM; Pinedo HM; Gerritsen WR
    J Virol; 2002 Mar; 76(6):2753-62. PubMed ID: 11861842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental treatment of ovarian cancers by adenovirus vectors combining receptor targeting and selective expression of tumor necrosis factor.
    Murugesan SR; Akiyama M; Einfeld DA; Wickham TJ; King CR
    Int J Oncol; 2007 Oct; 31(4):813-22. PubMed ID: 17786312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting.
    Jönsson F; Hagedorn C; Kreppel F
    J Vis Exp; 2018 Oct; (140):. PubMed ID: 30417881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted adenovirus vectors.
    Mizuguchi H; Hayakawa T
    Hum Gene Ther; 2004 Nov; 15(11):1034-44. PubMed ID: 15610604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein.
    Stevenson SC; Rollence M; Marshall-Neff J; McClelland A
    J Virol; 1997 Jun; 71(6):4782-90. PubMed ID: 9151872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting a recombinant adenovirus vector to HCC cells using a bifunctional Fab-antibody conjugate.
    Yoon SK; Mohr L; O'Riordan CR; Lachapelle A; Armentano D; Wands JR
    Biochem Biophys Res Commun; 2000 Jun; 272(2):497-504. PubMed ID: 10833442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and selection of targeted adenoviruses embodying optimized vector properties.
    Noureddini SC; Krendelshchikov A; Simonenko V; Hedley SJ; Douglas JT; Curiel DT; Korokhov N
    Virus Res; 2006 Mar; 116(1-2):185-95. PubMed ID: 16293334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105).
    Nettelbeck DM; Miller DW; Jérôme V; Zuzarte M; Watkins SJ; Hawkins RE; Müller R; Kontermann RE
    Mol Ther; 2001 Jun; 3(6):882-91. PubMed ID: 11407902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A targeted adenovirus vector displaying a human fibronectin type III domain-based monobody in a fiber protein.
    Matsui H; Sakurai F; Katayama K; Abe Y; Machitani M; Kurachi S; Tachibana M; Mizuguchi H
    Biomaterials; 2013 May; 34(16):4191-4201. PubMed ID: 23473963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced gene transfer to rabbit jugular veins by an adenovirus containing a cyclic RGD motif in the HI loop of the fiber knob.
    Hay CM; De Leon H; Jafari JD; Jakubczak JL; Mech CA; Hallenbeck PL; Powell SK; Liau G; Stevenson SC
    J Vasc Res; 2001; 38(4):315-23. PubMed ID: 11455202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redirecting adenoviruses to tumour cells using therapeutic antibodies: Generation of a versatile human bispecific adaptor.
    Vasiljevic S; Beale EV; Bonomelli C; Easthope IS; Pritchard LK; Seabright GE; Caputo AT; Scanlan CN; Dalziel M; Crispin M
    Mol Immunol; 2015 Dec; 68(2 Pt A):234-43. PubMed ID: 26391350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice.
    Romanczuk H; Galer CE; Zabner J; Barsomian G; Wadsworth SC; O'Riordan CR
    Hum Gene Ther; 1999 Nov; 10(16):2615-26. PubMed ID: 10566889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Gorilla Adenoviral Vector with Natural Lung Tropism Avoids Liver Toxicity and Is Amenable to Capsid Engineering and Vector Retargeting.
    Lu ZH; Dmitriev IP; Brough DE; Kashentseva EA; Li J; Curiel DT
    J Virol; 2020 May; 94(10):. PubMed ID: 32102889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge.
    Korokhov N; Mikheeva G; Krendelshchikov A; Belousova N; Simonenko V; Krendelshchikova V; Pereboev A; Kotov A; Kotova O; Triozzi PL; Aldrich WA; Douglas JT; Lo KM; Banerjee PT; Gillies SD; Curiel DT; Krasnykh V
    J Virol; 2003 Dec; 77(24):12931-40. PubMed ID: 14645549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal muscle gene transfer is not enhanced by an RGD capsid modification to high-capacity adenoviral vectors.
    Bilbao R; Reay DP; Hughes T; Biermann V; Volpers C; Goldberg L; Bergelson J; Kochanek S; Clemens PR
    Gene Ther; 2003 Oct; 10(21):1821-9. PubMed ID: 12960972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.